Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Sandip P. Patel"'
Autor:
Michael J. Dennis, Sophia Bylsma, Lisa Madlensky, Meghana S. Pagadala, Hannah Carter, Sandip P. Patel
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundImpaired DNA damage response (DDR) can affect immune checkpoint inhibitors (ICI) efficacy and lead to heightened immune activation. We assessed the impact of pathogenic or likely pathogenic (P/LP) germline DDR mutations on ICI response and
Externí odkaz:
https://doaj.org/article/1e0413811b3145389253abec7216b286
Autor:
Alexander S. Qian, Melody K. Schiaffino, Vinit Nalawade, Lara Aziz, Fernanda V. Pacheco, Bao Nguyen, Peter Vu, Sandip P. Patel, Maria Elena Martinez, James D. Murphy
Publikováno v:
Cancer Medicine, Vol 11, Iss 4, Pp 1192-1201 (2022)
Abstract Background Oncology rapidly shifted to telemedicine in response to the COVID‐19 pandemic. Telemedicine can increase access to healthcare, but recent research has shown disparities exist with telemedicine use during the pandemic. This study
Externí odkaz:
https://doaj.org/article/f3c67712bde54f63a5513d5ccbbb81f9
Autor:
David J. Benjamin, MD, Shuai Chen, PhD, Joanna B. Eldredge, MD, Shiruyeh Schokrpur, MD, Debory Li, Zhikuan Quan, MS, Jason W. Chan, MD, Amy L. Cummings, MD, Megan E. Daly, MD, Jonathan W. Goldman, MD, Matthew A. Gubens, MD, Jeremy P. Harris, MD, Mark W. Onaitis, MD, Viola W. Zhu, MD, PhD, Sandip P. Patel, MD, Karen Kelly, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 12, Pp 100427- (2022)
Introduction: There is a paucity of data on immune checkpoint inhibitors (ICIs) plus doublet chemotherapy (C) in patients with advanced lung cancer whose tumor harbors an actionable mutation. We sought to provide insight into the role of this combina
Externí odkaz:
https://doaj.org/article/3801fd9322224ff8af798db8607d43fe
Autor:
David S. Hong, Ajay K. Gopal, Alexander N. Shoushtari, Sandip P. Patel, Aiwu R. He, Toshihiko Doi, Suresh S. Ramalingam, Amita Patnaik, Shahneen Sandhu, Ying Chen, Craig B. Davis, Timothy S. Fisher, Bo Huang, Kolette D. Fly, Antoni Ribas
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Section HeadClinical/translational cancer immunotherapyBackgroundThe goal of this study was to estimate the objective response rate for utomilumab in adults with immune checkpoint inhibitor (ICI)-refractory melanoma and non–small-cell lung cancer (
Externí odkaz:
https://doaj.org/article/a396b9eb0e0b40ccbf67fc789b9b7881
Autor:
Lindsey M. Charo, Ramez N. Eskander, Ryosuke Okamura, Sandip P. Patel, Mina Nikanjam, Richard B. Lanman, David E. Piccioni, Shumei Kato, Michael T. McHale, Razelle Kurzrock
Publikováno v:
Molecular Oncology, Vol 15, Iss 1, Pp 67-79 (2021)
Molecular characterization of cancers is important in dictating prognostic factors and directing therapy. Next‐generation sequencing of plasma circulating tumor DNA (ctDNA) offers less invasive, more convenient collection, and a more real‐time re
Externí odkaz:
https://doaj.org/article/7a9c92dc08dc477d922323db2172ffe6
Autor:
Kedar Kirtane, Maie St. John, Harry Fuentes-Bayne, Sandip P. Patel, Armen Mardiros, Han Xu, Eric W. Ng, William Y. Go, Deborah J. Wong, John B. Sunwoo, John S. Welch
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 24, p 7259 (2022)
Head and neck squamous cell cancers (HNSCCs) represent a diverse group of tumors emerging within different mucosal surfaces of the oral cavity, nasopharynx, oropharynx, larynx, and hypopharynx. HNSCCs share common clinical risk factors and genomic fe
Externí odkaz:
https://doaj.org/article/bf9d017b86f044b5ae7ec4d72124d29d
Autor:
Sandip Kumar Patel, Ritesh Patel
Publikováno v:
International Journal of Mathematical, Engineering and Management Sciences, Vol 7, Iss 5, Pp 697-716 (2022)
One of the most promising frameworks is the fog computing paradigm for time-sensitive applications such as IoT (Internet of Things). Though it is an extended type of computing paradigm, which is mainly used to support cloud computing for executing de
Externí odkaz:
https://doaj.org/article/749a31103c924c3697eca44c83343f43
Autor:
Chisaka Kuehnemann, Kang-Quan Hu, Kayla Butera, Sandip K. Patel, Joanna Bons, Birgit Schilling, Cristina Aguayo-Mazzucato, Christopher D. Wiley
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Cellular senescence is a stress or damage response by which a cell adopts of state of essentially permanent proliferative arrest, coupled to the secretion of a number of biologically active molecules. This senescence-associated secretory phenotype (S
Externí odkaz:
https://doaj.org/article/003825a129bd4f75b929b9148cea82e1
Autor:
Daniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, Marium Husain, James S. Bassett, Lei Wang, Gabriel Tinoco, Sandip H. Patel, Jarred Burkart, Abdul Miah, Mingjia Li, Andrew Johns, Madison Grogan, David P. Carbone, Claire F. Verschraegen, Kari L. Kendra, Gregory A. Otterson, Lang Li, Carolyn J. Presley, Dwight H. Owen
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background The microbiome has been shown to affect the response to Immune Checkpoint Inhibitors (ICIs) in a small number of cancers and in preclinical models. Here, we sought to broadly survey cancers to identify those in which the microbiom
Externí odkaz:
https://doaj.org/article/a2ea93cf4e3c437189a96df81b027495
Autor:
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm DeCamp, Thomas J. Dilling, Jonathan Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip P. Patel, Tejas Patil, Patricio M. Polanco, Gregory J. Riely, Jonathan Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:340-350
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known as perioperative) systemic therapy opt